218-OR: Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 218-OR
Author(s):  
PIOTR J. BACHUL ◽  
JUSTYNA E. GOLEBIEWSKA ◽  
MONICA PARA ◽  
FILIP ANTIC ◽  
LINDSAY BASTO ◽  
...  
1999 ◽  
Vol 77 (1) ◽  
pp. 140-143 ◽  
Author(s):  
R. G. Bretzel ◽  
D. Brandhorst ◽  
H. Brandhorst ◽  
M. Eckhard ◽  
W. Ernst ◽  
...  

Radiology ◽  
2003 ◽  
Vol 229 (1) ◽  
pp. 165-170 ◽  
Author(s):  
Richard J. T. Owen ◽  
Edmond A. Ryan ◽  
Kevin O’Kelly ◽  
Jonathan R. T. Lakey ◽  
Mairin C. McCarthy ◽  
...  

1999 ◽  
Vol 16 (3) ◽  
pp. 228-232 ◽  
Author(s):  
G. Riccardi ◽  
R. Giacco ◽  
M. Parillo ◽  
S. Turco ◽  
A. A. Rivellese ◽  
...  

2020 ◽  
Vol 8 (12) ◽  
pp. 2759-2762
Author(s):  
Brigette Clarke ◽  
Tom Loudovaris ◽  
Toni Radford ◽  
Chris Drogemuller ◽  
Patrick Toby Coates ◽  
...  

2010 ◽  
Vol 6 (5) ◽  
pp. 274-284 ◽  
Author(s):  
Amy Hughes ◽  
Claire Jessup ◽  
Chris Drogemuller ◽  
Daisy Mohanasundaram ◽  
Clyde Milner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document